Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Peng, Shuanga; 1 | Zhang, Shiyua; 1 | Fan, Xingchenb; 1 | Zhu, Jingfengc | Liu, Chengd | Yue, Yuline; * | Wang, Tongshana; * | Zhu, Weia; *
Affiliations: [a] Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China | [b] Department of Geriatrics, The First People’s Hospital of Lianyungang, Lianyungang, Jiangsu, China | [c] Department of Nephrology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China | [d] Department of Gastroenterology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China | [e] Department of Laboratory, Children’s Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Correspondence: [*] Corresponding authors: Wei Zhu, Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. Tel.: +86 139 13894911, E-mail: [email protected]. Tongshan Wang, Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. Tel.: +86 137 05174300, E-mail: [email protected]. Yulin Yue, Department of Laboratory, Children’s Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. Tel.: +86 177 88388125, E-mail: [email protected].
Note: [1] Shuang Peng, Shiyu Zhang, and Xingchen Fan have contributed equally to this work.
Abstract: BACKGROUND: MicroRNAs regulating mRNA expression by targeting at mRNAs is known constructive in tumor occurrence, immune escape, and metastasis. OBJECTIVE: This research aims at finding negatively regulatory miRNA-mRNA pairs in esophageal squamous cell carcinoma (ESCC). METHODS: GENE expression data of The Cancer Genome Atlas (TCGA) and GEO database were employed in differently expressed RNA and miRNA (DE-miRNAs/DE-mRNAs) screening. Function analysis was conducted with DAVID-mirPath. MiRNA-mRNA axes were identified by MiRTarBase and TarBase and verified in esophageal specimen by real-time reverse transcription polymerase chain reaction (RT-qPCR). Receiver operation characteristic (ROC) curve and Decision Curve Analysis (DCA) were applied in miRNA-mRNA pairs predictive value estimation. Interactions between miRNA-mRNA regulatory pairs and immune features were analyzed using CIBERSORT. RESULTS: Combining TCGA database, 4 miRNA and 10 mRNA GEO datasets, totally 26 DE-miRNAs (13 up and 13 down) and 114 DE-mRNAs (64 up and 50 down) were considered significant. MiRTarBase and TarBase identified 37 reverse regulation miRNA-mRNA pairs, 14 of which had been observed in esophageal tissue or cell line. Through analysis of RT-qPCR outcome, miR-106b-5p/KIAA0232 signature was chosen as characteristic pair of ESCC. ROC and DCA verified the predictive value of model containing miRNA-mRNA axis in ESCC. Via affecting mast cells, miR-106b-5p/KIAA0232 may contribute to tumor microenvironment. CONCLUSIONS: The diagnostic model of miRNA-mRNA pair in ESCC was established. Their complex role in ESCC pathogenesis especially tumor immunity was partly disclosed.
Keywords: Biomarkers, miRNA-mRNA interaction, esophageal squamous cell carcinoma, TCGA, GEO, PCR
DOI: 10.3233/CBM-220309
Journal: Cancer Biomarkers, vol. 37, no. 3, pp. 191-203, 2023
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]